» Articles » PMID: 11322751

Revisiting Emerging Infectious Diseases: the Unfinished Agenda

Overview
Publisher Springer
Specialty Public Health
Date 2001 Apr 27
PMID 11322751
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Infectious diseases present a formidable threat to the world today. Not only are new infectious diseases emerging, but those presumed to be contained or eradicated are re-emerging. Developing nations, with the least resources to respond, bear the greatest burden of this threat. However, with the potential to spread rapidly and ubiquitously, infectious diseases present a significant risk to the health and development of all nations. No country or population is immune, and geographic and political barriers offer little protection. Many factors facilitate the spread of infectious diseases, including globalization of travel and trade, weakening of national and international public health infrastructure, deterioration of socioeconomic conditions, and heightened political and civil strife in some developing nations. These conditions render populations more vulnerable to infections and provide an environment conducive to the transmission of infectious diseases. Compounding these risk factors is the emergence of another threat: antimicrobial resistance. Antimicrobial drugs are rapidly losing their effectiveness because of their misuse. As a result, the global health community is confronted with the daunting task of combating more offenders with fewer defenses.

Citing Articles

Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.

Nii-Trebi N Biomed Res Int. 2017; 2017:5245021.

PMID: 28286767 PMC: 5327784. DOI: 10.1155/2017/5245021.


The changing disease-scape in the third epidemiological transition.

Harper K, Armelagos G Int J Environ Res Public Health. 2010; 7(2):675-97.

PMID: 20616997 PMC: 2872288. DOI: 10.3390/ijerph7020675.


Environmental determinants of infectious disease: a framework for tracking causal links and guiding public health research.

Eisenberg J, Desai M, Levy K, Bates S, Liang S, Naumoff K Environ Health Perspect. 2007; 115(8):1216-23.

PMID: 17687450 PMC: 1940110. DOI: 10.1289/ehp.9806.


Emerging and re-emerging infectious diseases: review of general contributing factors and of West Nile virus.

Ligon B Semin Pediatr Infect Dis. 2004; 15(3):199-205.

PMID: 15480966 PMC: 7129447. DOI: 10.1053/j.spid.2004.08.001.


Rapid response research to emerging infectious diseases: lessons from SARS.

Finlay B, See R, Brunham R Nat Rev Microbiol. 2004; 2(7):602-7.

PMID: 15197395 PMC: 7097457. DOI: 10.1038/nrmicro930.

References
1.
Dye C, Scheele S, Dolin P, Pathania V, Raviglione M . Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999; 282(7):677-86. DOI: 10.1001/jama.282.7.677. View

2.
Raviglione M, Dye C, Schmidt S, Kochi A . Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project. Lancet. 1997; 350(9078):624-9. DOI: 10.1016/s0140-6736(97)04146-9. View

3.
Bond P . Globalization, pharmaceutical pricing, and South African health policy: managing confrontation with U.S. firms and politicians. Int J Health Serv. 2000; 29(4):765-92. DOI: 10.2190/4MA6-53E3-LE1X-C1YY. View

4.
Nyonator F, Kutzin J . Health for some? The effects of user fees in the Volta Region of Ghana. Health Policy Plan. 2000; 14(4):329-41. DOI: 10.1093/heapol/14.4.329. View